1. Home
  2. LEGN vs ALV Comparison

LEGN vs ALV Comparison

Compare LEGN & ALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • ALV
  • Stock Information
  • Founded
  • LEGN 2014
  • ALV 1953
  • Country
  • LEGN United States
  • ALV Sweden
  • Employees
  • LEGN N/A
  • ALV N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • ALV Auto Parts:O.E.M.
  • Sector
  • LEGN Health Care
  • ALV Consumer Discretionary
  • Exchange
  • LEGN Nasdaq
  • ALV Nasdaq
  • Market Cap
  • LEGN 7.0B
  • ALV 7.6B
  • IPO Year
  • LEGN 2020
  • ALV 1997
  • Fundamental
  • Price
  • LEGN $32.80
  • ALV $86.34
  • Analyst Decision
  • LEGN Strong Buy
  • ALV Buy
  • Analyst Count
  • LEGN 12
  • ALV 12
  • Target Price
  • LEGN $79.00
  • ALV $113.75
  • AVG Volume (30 Days)
  • LEGN 1.6M
  • ALV 1.2M
  • Earning Date
  • LEGN 05-12-2025
  • ALV 04-16-2025
  • Dividend Yield
  • LEGN N/A
  • ALV 3.24%
  • EPS Growth
  • LEGN N/A
  • ALV 35.84
  • EPS
  • LEGN N/A
  • ALV 8.68
  • Revenue
  • LEGN $627,241,000.00
  • ALV $10,353,000,000.00
  • Revenue This Year
  • LEGN $66.92
  • ALV $0.93
  • Revenue Next Year
  • LEGN $51.77
  • ALV $4.73
  • P/E Ratio
  • LEGN N/A
  • ALV $9.94
  • Revenue Growth
  • LEGN 119.97
  • ALV N/A
  • 52 Week Low
  • LEGN $29.27
  • ALV $75.49
  • 52 Week High
  • LEGN $60.87
  • ALV $129.38
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 45.92
  • ALV 49.11
  • Support Level
  • LEGN $29.27
  • ALV $75.49
  • Resistance Level
  • LEGN $35.11
  • ALV $89.90
  • Average True Range (ATR)
  • LEGN 1.89
  • ALV 3.66
  • MACD
  • LEGN 0.16
  • ALV 0.49
  • Stochastic Oscillator
  • LEGN 60.48
  • ALV 68.93

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About ALV Autoliv Inc.

Autoliv is the global leader in passive safety components and systems for the auto industry. Products include seat belts, frontal air bags, side-impact air bags, air bag inflators, and steering wheels. The Renault-Nissan-Mitsubishi alliance is the company's largest customer at 10% of 2023 revenue, with Stellantis accounting for 10% and Volkswagen 9%. At 34% of 2023 revenue, the Americas was Autoliv's largest geographic region, followed by Europe at 27%, China at 20%, and rest of world at 19%.

Share on Social Networks: